Related Experiment Video
Updated: Aug 7, 2026

Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
Clinical manifestations in neuropathologically defined subgroups of vascular dementia
Ulla Andin1, Lars Gustafson, Arne Brun
1Department of Psychogeriatrics, Lund University Hospital, Sweden. ulla.andin@orebroll.se
Insights
This study analyzed clinical features across vascular dementia (VaD) subgroups. Large Vessel Dementia (LVD) showed the highest prevalence of cardiovascular features, aiding diagnostic understanding.
Area of Science:
- Neurology
- Pathology
- Gerontology
Background:
- Vascular Dementia (VaD) encompasses diverse neuropathological subtypes.
- Clinical manifestations can vary significantly among these subtypes, impacting diagnosis and management.
- Understanding these differences is crucial for targeted therapeutic strategies.
Purpose of the Study:
- To investigate cardio-cerebrovascular disease and clinical features in neuropathologically defined VaD subgroups.
- To compare clinical presentations, including falls, dizziness, and cognitive changes, across pure Small Vessel Dementia (SVD), SVD-Alzheimer's disease (SVD-AD), Large Vessel Dementia (LVD), and Hypoxic Hypoperfusive Dementia (HHD).
Main Methods:
- Analysis of 175 neuropathologically verified VaD cases.
- Selection of pure SVD (n=36), SVD-AD (n=38), pure LVD (n=7), and pure HHD (n=6) subgroups.
- Evaluation of cardio-cerebrovascular features, hypertension, transient ischemic attacks (TIA), and complete cerebrovascular lesions (CVL).
Main Results:
- No significant differences in cardiovascular symptoms, hypertension, TIA, or CVL between pure SVD and SVD-AD groups.
- Marked variation in cardiovascular features across pure VaD subgroups, with LVD exhibiting the highest prevalence.
- Hypertension was common in LVD and SVD but rare in HHD; TIA/CVL were most frequent in LVD.
Conclusions:
- Significant clinical similarities and differences exist between pathologically defined VaD subgroups.
- Findings contribute to understanding the etiopathogenesis and diagnosis of VaD.
- Provides a basis for developing targeted treatment strategies for VaD.
Aims:
To study cardio-cerebrovascular disease and clinical features, such as falls, dizziness/unsteadiness, urinary incontinence, hallucinations/delusions and delirium in neuropathologically defined subgroups of vascular Dementia (VaD): pure Small Vessel Dementia (SVD), combined SVD and Alzheimer's disease (SVD-AD), pure Large Vessel Dementia (LVD) and pure Hypoxic Hypoperfusive Dementia (HHD), and to analyse the clinical differences between these groups.
Materials And Methods:
From 175 consecutive cases with neuropathologically verified VaD cases with pure SVD (n = 36) and SVD-AD (n = 38) with varying severity of AD pathology were selected and studied with respect to cardio-cerebrovascular and other clinical features. Furthermore, a comparison between pure SVD, pure LVD (n = 7) and pure HHD (n = 6) was made.
Results:
Neither cardiovascular symptoms, hypertension, Transitoric Ischemic Attacks (TIA) nor complete cerebrovascular lesions (CVL) differed significantly between the pure SVD and SVD-AD groups. However, a wide variation of clinical features were reported. The prevalence of cardiovascular features varied markedly in the pure groups, with the highest prevalence consistently found in the LVD group. Hypertension was common in the pure LVD and SVD-groups, while it was a rare finding in the HHD-group. TIA and/or CVL were, as expected, most common in the LVD-group.
Conclusion:
In conclusion, this longitudinal and retrospective study of VaD shows important clinical similarities as well as differences between pathologically defined subgroups. Hopefully these findings will contribute to a better understanding of etiopathogenetic and diagnostic issues and form a solid basis for possible treatment strategies in VaD.
Related Concept Videos
Dementia l: Introduction
Alzheimer Disease l: Introduction
Dementia
The progression of dementia is generally gradual.
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Alzheimer Disease ll: Pathophysiology

